Norman Sussman - Jan 6, 2022 Form 4 Insider Report for DURECT CORP (DRRX)

Role
Chief Medical Officer
Signature
/s/ Norman Sussman
Stock symbol
DRRX
Transactions as of
Jan 6, 2022
Transactions value $
$0
Form type
4
Date filed
1/10/2022, 06:40 PM
Next filing
Feb 23, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRRX Stock Option (right to buy) Award $0 +398K $0.00 398K Jan 6, 2022 Common Stock 398K $0.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.